Nephros Inc

Nephros Inc(NEPH)股票分析

$2.833

-0.236 (-8.32%)收盘时

Loading chart…
最高
3.080
开盘
3.080
成交量加权均价
2.88
成交量
104.01K
市值
22.04M
最低
2.720
成交额
299.30K
企业价值/息税折旧摊销前利润(TTM)
5.64

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

AI 分析 of Nephros Inc (NEPH)

持有

Nephros Inc is currently not a strong buy due to its low RSI of 16.83, indicating oversold conditions, and a significant 40.36% year-to-date decline. While the company reported record revenue of $6 million in Q2 2026 and a net income increase of over 400% to approximately $1.2 million, the stock's recent performance has been poor, with a 10.63% drop over the last five days. The main risk is its high debt to equity ratio of 6.17%, which could impact financial stability.

估值指标

Nephros Inc(NEPH)当前预期市盈率为 0.00,5 年平均预期市盈率为 -23.55。

预期市盈率

合理
5 年均值 P/E
-23.55
当前P/E
0.00
高估
118.86
低估
-165.96

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
3.79
当前EV/EBITDA
5.64
高估
28.55
低估
-20.97

预期市销率

合理
5 年均值 P/S
1.85
当前P/S
1.31
高估
3.01
低估
0.69

Alphio AI 对 NEPH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%NEPH

$3.45

情景价格

基

基准

基准 · 50%NEPH

$2.82

情景价格

悲

悲观

悲观 · 25%NEPH

$2.02

情景价格

事件时间线

2026-08-06 (ET)

18:00:00

Nephros Reports Q2 Revenue of $6.02M

2026-02-13 (ET)

08:20:00

Nephros Enters Puerto Rican Market to Address Water Quality Needs

2025-12-11 (ET)

09:10:00

Nephros Launches Water Institute to Enhance Industry Education

2025-10-08 (ET)

09:11:53

Nephros Introduces New Filter for PFAS Removal

2024-10-24 (ET)

09:09:57

Nephros launches HydraGuard 20" UltraFilter

资讯

NEPH 常见问题 —— 由 Alphio AI 解答

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. It operates in the Industrials sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Nephros Inc is currently not a strong buy due to its low RSI of 16.83, indicating oversold conditions, and a significant 40.36% year-to-date decline. While the company reported record revenue of $6 million in Q2 2026 and a net income increase of over 400% to approximately $1.2 million, the stock's recent performance has been poor, with a 10.63% drop over the last five days. The main risk is its high debt to equity ratio of 6.17%, which could impact financial stability.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易